Repression of Human Telomerase Reverse Transcriptase Using Artificial Zinc Finger Transcription Factors

Abstract

Telomerase activation is a key step in the development of human cancers. Expression of the catalytic subunit, human telomerase reverse transcriptase (hTERT), represents the limiting factor for telomerase activity. In this study, we have used artificial zinc finger protein (ZFP) transcription factors (TF) to repress the expression of hTERT in human cancer cell lines at the transcriptional level. We have constructed four-fingered ZFPs derived from the human genome which binds 12-bp recognition sequences within the promoter of the hTERT gene and fused them with a KRAB repressor domain to create a potent transcriptional repressor. Luciferase activity was decreased by >80% in all of the transcriptional repressors with luciferase reporter assay. When they were transfected into the telomerase-positive HEK293 cell line, a decrease of mRNA level and telomerase activity together with shortening of telomere length was observed. Actual growth of HEK293 cells was also inhibited by transfection of artificial ZFP-TFs. The repression was maintained for 100 days of culture. The repression of telomerase expression by artificial ZFP-TFs targeting the promoter region of the hTERT presents a new promising strategy for inhibiting the growth of human cancer cells. Mol Cancer Res; 8(2); 246-53.

Firefly Luciferase and Rluc8 Exhibit Differential Sensitivity to Oxidative Stress in Apoptotic Cells

“…Bioluminescent reporters are regularly used to study the regulation of gene expression by cis- or trans-acting factors, such as gene regulatory elements[1], transcription factors[2], or exogenous regulators[3]. Luciferase enzymes have also been used for tracking cell migration[4] in living subjects and monitoring intracellular molecular interactions[5].…”

Epigenetic regulation of satellite cell activation during muscle regeneration

“…An artificial transcriptional zinc-finger-mediated upregulation of telomerase activity through epigenetic mechanisms specifically in satellite cells could perhaps lead to increased self-renewal such that the stem cells do not become depleted as the need for repair continues over the lifetime of the patient. A similar approach has recently been explored to repress expression of telomerase in transformed cells using artificial zinc fingers fused to the transcriptional repressor domain of KRAB [71]. Epigenetic enzymes could thus represent a viable target for future gene therapies to permit muscle repair in muscular dystrophy patients.…”

Engineering Transcription Factors in Breast Cancer Stem Cells

“…Recently regulated genes include: mammary serine protease inhibitor (maspin) [103,118], dystrophin-related gene utrophin [119], vascular endothelial growth factor A (VEGF-A) [120,121], gamma-globin [122], heme oxygenase-1 gene (HMOX1) [123], glial cell line-derived neurotrophic factor gene (GDNF) [124], derived tyrosine kinase receptors ErbB2 [90,125], and ErbB3 [100,125]. Genes that were successfully downregulated by ATFs comprise: VEGF-A [120,121], ErbB2 [90,125], ErbB3 [100], the human telomerase reverse transcriptase (hTERT) [126], the nuclear hormone receptor PPARγ gene (PPARγ) [127], and the repression of the checkpoint kinase 2 (CHK2) gene [88]. The most recent application of engineered ZF DBDs embrace the ability to specifically modify the genome using zinc finger nucleases (ZFNs).…”